Cc1cc(-c2nc(C)c(-c3nnc(SCC(=O)Nc4ccc(Cl)cc4)n3C)s2)no1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?